The new surgical method, called NeuroSAFE, preserves the nerves that run through the prostate’s outer layers, which are ...

Men who avoided prostate cancer screening appointments were significantly more likely to die from the disease, according to ...

A campaign has been launched to encourage more men to check their prostate cancer risks. According to Barnsley Metropolitan ...

The OPTIMUM study found 4.5% more clinically significant cancers among men who underwent micro-ultrasound–guided biopsies of ...

A new study has revealed that men who don't heed recommendations for prostate cancer screenings are at a significantly higher ...

Auburn announced in late February that Freeze had been diagnosed with an early form of prostate cancer, but is expected to ...

Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...

FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with ...

The FDA approved a radioligand therapy for earlier use prior to chemotherapy in patients with prostate-specific membrane ...

A recent breakthrough study highlights how a simple at-home urine test could accurately detect prostate cancer. Researchers ...

After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, opening up the radioligand therapy to a much ...

According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during ...